Jesus Usón Minimally Invasive Surgery Centre (JUMISC)
|
|
Address:
|
Carretera N-521, km 41,8, Cáceres, PO: 10071 (Spain)
|
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
|
|
Address:
|
Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, PO: 28029 (Spain)
|
Biological/Biomedical Engineering and Biotechnology/Nanotechnology Research Facilities
Biomedical Imaging Facilities
Centralised Computing Facilities
Micro- and Nanotechnology facilities
Analytical Facilities
Chemistry and Material Sciences
- Supply nanomaterials for applications in Nanomedicine: therapy, drug delivery, contras agents (MRI, fluorescence) & theranostic - Pure active pharmaceutical ingredients with controlled nansotructure,
Preclinical validation of biomaterials including surface and mechanical characterization and in vitro and in vivo biological properties with appropriated animal models, at either regulatory (cGLP) or non-regulatory conditions: - Preclinical validation - Surface and mechanical characterization - Adhesion of bacteria: biofilms - Biocompatibility
In vivo Validation of medical devices for determined applications in different animal models
Customized design and production services of biological molecules for Tissue Engineering, Intelligent Devices, Implants, and specially Therapeutic Nanoconjugates and Biosensors by providing for applications such as: − Therapeutic agents - Targeting − Surfaces functionalization: Tissue engineering/scaffolds & biosensors
Development of prototypes and biosensing devices for diagnostic, production of bioreceptor against identified biomarkers an detection of biomarkers for diagnostic, follow-up and prognostic of diseases by NMR spectroscopies in biofluids and tissues.
In vivo validation of contrast agents and development of nanoconjugates as contrast agents for MRI and fluorescence: - Nanoparticles - Validation of NPs for glioma - Validation of Contras agents - Nanocojugates for fluorescence - Nanocojugates for MRI
Preclinical characterization of nanomedicines including physicochemical properties, in vitro and in vivo biological properties (immunology, toxicology an efficacy with appropriated animal models, at either regulatory (cGLP) or non-regulatory conditions: - Complete cascade characterization - Physicochemical characterization - In vitro characterization - In vivo characterization
Design and production of scaffolds for tissue engineering: - Scaffolds - Functionalized scaffolds
Supply nanoconjugates for applications in Nanomedicine: therapy, contrast agents (MRI) & theranostic. - Bioconjugation - Nanoconjugation - Micro & nanoencapsulation